Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)

NCT02920892 is registered in ClinicalTrials.gov with Elizabeth Berry-Kravis as lead sponsor.

NCT NCT02920892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02920892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)
Lead sponsor
Elizabeth Berry-Kravis
Phase
Phase 2
Overall status
Completed
Start date
August 17, 2017
Completion date
May 17, 2022
Enrollment
110 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x syndrome